HealthCareEquipment.org


Status: In Stock

CONTAK RENEWAL 3


A Cardiac Resynchronization Therapy Defibrillator (CRT-D) Related Image

(Not Necessarily related to the device)

Description:

CONTAK RENEWAL 3 by Boston Scientific Corp.

The CONTAK RENEWAL 3 is a sophisticated medical device designed and manufactured by Boston Scientific Corp., a renowned name in the realm of medical technology. Serving as an advanced cardiac resynchronization therapy defibrillator (CRT-D), it is primarily used to manage heart rhythm disorders.

This cutting-edge CRT-D device provides a comprehensive solution for cardiac care, offering both heart rhythm management and defibrillator functionality. It helps heart chambers beat more synchronously, improving the heart's blood pumping efficiency, thereby benefiting patients with heart failure. Simultaneously, it maintains the capability to deliver a lifesaving shock should a lethal heart rhythm disorder occur.

Equipped with Amplia Quad CRT-D technology, the CONTAK RENEWAL 3 offers personalized therapy options, effectively adapting to the individual patient's needs. This involves ventricular and atrial arrhythmia therapies and advanced heart failure diagnostics. Those features significantly enhance medical professionals' ability to monitor and manage a variety of complex cardiac conditions, hence promoting patient safety and improving their overall quality of life.

With its multi-purpose functionality, the CONTAK RENEWAL 3 stands as a pivotal tool in comprehensive cardiac care, serving both the patient and the healthcare professional with precision and reliability.


Primary Use:

Primary Medical Use of CONTAK RENEWAL 3

The CONTAK RENEWAL 3 falls under the category of Cardiac Rhythm Management Devices. Its primary use lies in managing and monitoring the heart's rhythm in patients with certain types of heart disease. Specifically, this device is an implantable cardioverter defibrillator (ICD) and cardiac resynchronization therapy defibrillator (CRT-D).

As an Implantable Cardioverter Defibrillator (ICD), the CONTAK RENEWAL 3 is designed to help prevent sudden cardiac arrest in patients with life-threatening arrhythmias. The device continuously monitors the heart rhythm, and if a dangerous arrhythmia is detected, it delivers an electric pulse or shock to the heart to restore a normal rhythm.

In its additional role as a <


How It Works:

Understanding the CONTAK RENEWAL 3 Device

The CONTAK RENEWAL 3 is part of the advanced medical devices used in Cardiac Rhythm Management. This device is essentially a highly specialized pacemaker, designed to help control problematic heart rhythms, or arrhythmias. It is intricately engineered to not only detect but to also regulate the electrical activity of the heart.

How CONTAK RENEWAL 3 Works

Implant and Detection
The CONTAK RENEWAL 3 device is surgically implanted into the chest of a patient who suffers from heart rhythm problems. After implantation, the device starts its role by continuously monitoring the patient's heart rhythm. It uses highly sensitive, advanced algorithms to detect any irregularities in the electrical activity of the heart – these could be heartbeats that are too slow (bradycardia), too fast (tachycardia), or completely irregular (arrhythmia). Response and Regulation
Once an anomalous rhythm is detected, the CONTAK RENEWAL 3 springs into action. The device sends electrical impulses to the heart that are specifically calibrated to correct the detected irregularity and guide the heart back to a normal rhythm. Depending on the nature of the issue, these impulses may speed up a slow heart rhythm, slow down a fast one, or reset an irregular rhythm entirely. Data Management and Communication
Beyond its primary functions of detection and correction, CONTAK RENEWAL 3 also stores data on the detected arrhythmias and the therapeutic interventions it carried out. Furthermore, the device is capable of wirelessly transmitting this information to healthcare providers. This allows for a continuous Cardiac Monitoring of the patient's heart rhythm, providing valuable insights into the effectiveness of the therapy and helping with determining further treatment plans. In sum, the CONTAK RENEWAL 3 is an extraordinary device that fuses detection, intervention, and communication into a compact, life-saving device. It not only manages potentially dangerous heart rhythms, but does so while keeping both the patient and their healthcare provider informed on the status of the patient's heart health.

Manufacturer:

Boston Scientific Corp.


Status: In Stock


Are you the owner or manufacturer of this device? Need to update anything on this page or get in touch with us? Click here.

×

Owner/Manufacturer Registration

Thank you for your submission!

We will get in touch with you shortly.